Compare EYPT & INOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EYPT | INOD |
|---|---|---|
| Founded | 1987 | 1988 |
| Country | United States | United States |
| Employees | N/A | 3000 |
| Industry | Biotechnology: Laboratory Analytical Instruments | EDP Services |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2005 | 1996 |
| Metric | EYPT | INOD |
|---|---|---|
| Price | $12.86 | $45.01 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | $31.80 | ★ $100.00 |
| AVG Volume (30 Days) | ★ 1.2M | 804.7K |
| Earning Date | 03-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.37 |
| EPS | N/A | ★ 0.92 |
| Revenue | $7,539,000.00 | ★ $86,775,000.00 |
| Revenue This Year | N/A | $35.60 |
| Revenue Next Year | $1,031.72 | $29.67 |
| P/E Ratio | ★ N/A | $47.34 |
| Revenue Growth | N/A | ★ 9.84 |
| 52 Week Low | $3.91 | $26.70 |
| 52 Week High | $19.11 | $93.82 |
| Indicator | EYPT | INOD |
|---|---|---|
| Relative Strength Index (RSI) | 36.53 | 47.84 |
| Support Level | $12.05 | $44.25 |
| Resistance Level | $13.32 | $52.34 |
| Average True Range (ATR) | 1.01 | 2.01 |
| MACD | -0.33 | 0.42 |
| Stochastic Oscillator | 3.45 | 60.41 |
EyePoint Inc focuses on developing and commercializing innovative therapeutics for serious retinal diseases. It develops therapies for serious retinal diseases to provide durable treatments that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained release product candidate for retinal diseases with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.
Innodata Inc is a data engineering company. It is helping companies deploy and integrate AI into their operations and products and providing AI-enabled industry platforms. The Company's operations are classified in three reporting segments: Digital Data Solutions (DDS), Synodex and Agility. Key revenue is generated from DDS segment provides AI data preparation services, collecting or creating training data, annotating training data, and training AI algorithms for its customers, and AI model deployment and integration. It also provides a range of data engineering support services including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management.